Literature DB >> 6118480

Down Syndrome and acute leukaemia: increased risk may be due to trisomy 21.

J D Rowley.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6118480     DOI： 10.1016/s0140-6736(81)91218-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia.

Authors:  J Gao; P Erickson; K Gardiner; M M Le Beau; M O Diaz; D Patterson; J D Rowley; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Isolation, characterization, and regional mapping of microclones from a human chromosome 21 microdissection library.

Authors:  J Yu; J Hartz; Y Xu; R M Gemmill; J R Korenberg; D Patterson; F T Kao
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions.

Authors:  M C Ghozi; Y Bernstein; V Negreanu; D Levanon; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  Submicroscopic duplication of chromosome 21 and trisomy 21 phenotype (Down syndrome).

Authors:  J M Delabar; P M Sinet; B Chadefaux; A Nicole; A Gegonne; D Stehelin; F Fridlansky; N Créau-Goldberg; C Turleau; J de Grouchy
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

5.  Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids.

Authors:  M L Van Keuren; P C Watkins; H A Drabkin; E W Jabs; J F Gusella; D Patterson
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

Review 6.  Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.

Authors:  Erik Hefti; Javier G Blanco
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

7.  Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.

Authors:  A O Wilkie; C Kitchen; A Oakhill; R T Howell; P J Berry
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

8.  Use of restriction fragment length polymorphic probes in the analysis of Down's syndrome trisomy.

Authors:  A M Millington-Ward; P L Pearson
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

9.  Congenital leukemia in an infant with Down syndrome.

Authors:  S Swaminathan; L S Arya; I C Verma; H Patil
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

10.  Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Authors:  Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.